scispace - formally typeset
P

Pierre Lavallee

Researcher at Boehringer Ingelheim

Publications -  23
Citations -  924

Pierre Lavallee is an academic researcher from Boehringer Ingelheim. The author has contributed to research in topics: Thromboxane B2 & HIV Protease Inhibitor. The author has an hindex of 12, co-authored 23 publications receiving 908 citations.

Papers
More filters
Journal ArticleDOI

The Preparation and Synthetic Utility of tert-Butyldiphenylsilyl Ethers

TL;DR: The utility of tert-butyldiphenylsilyl chloride as a reagent for the protection of hydroxyl groups was explored in this article, where the corresponding tert-BDPSi ethers have much greater stability to acids, and under...
Journal ArticleDOI

A stereospecifie, total synthesis of thromboxane B2

TL;DR: In this article, a stereospecific, total synthesis of crystalline thromboxane B2 from D-glucose is described, and the synthesis is shown to be stable.
Journal ArticleDOI

Practical, stereoselective synthesis of palinavir, a potent hiv protease inhibitor

TL;DR: A highly convergent and stereoselective synthesis which is amenable to the preparation of multikilogram quantities ofPalinavir, a potent peptidomimetic-based HIV protease inhibitor, is developed.
Journal ArticleDOI

Specific inhibition of ribonucleotide reductases by peptides corresponding to the C-terminal of their second subunit.

TL;DR: It is illustrated that inhibition of ribonucleotide reductases by peptides corresponding to the C-terminal of subunit R2 is also observed for the enzyme isolated from Escherichia coli, hamster, and human cells.